HAEMONETICS CORP MASS shareholders Q3 2023

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 52 filers reported holding HAEMONETICS CORP MASS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

HAEMONETICS CORP MASS shareholders Q3 2023
NameSharesValueWeighting ↓
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,705,0001.15%
Context Capital Management, LLC 14,558$12,6601.02%
Quaero Capital S.A. 1,200,000$1,042,4400.99%
READYSTATE ASSET MANAGEMENT LP 22,200,000$19,369,5000.97%
DeepCurrents Investment Group LLC 24,371,000$21,212,5170.92%
ADVENT CAPITAL MANAGEMENT /DE/ 39,904,000$34,816,2400.81%
SSI INVESTMENT MANAGEMENT LLC 10,872,000$9,431,4620.77%
Empyrean Capital Partners, LP 13,500,000$11,696,9590.72%
MACKAY SHIELDS LLC 29,294,000$25,825,1100.71%
Aequim Alternative Investments LP 20,500,000$17,886,2500.68%
LINDEN ADVISORS LP 50,483,000$43,866,0740.45%
WOLVERINE ASSET MANAGEMENT LLC 39,207,000$34,020,3430.38%
Wellesley Asset Management 5,712,000$4,963,5000.25%
CAMDEN ASSET MANAGEMENT L P /CA 7,500,000$6,506,2500.24%
OAKTREE CAPITAL MANAGEMENT LP 18,928,000$16,514,6800.24%
CORBYN INVESTMENT MANAGEMENT INC/MD 510,000$444,9750.23%
Verition Fund Management LLC 18,792$16,396,0200.19%
CSS LLC/IL 2,500,000$2,171,4520.14%
Kohlberg Kravis Roberts & Co. L.P. 3,870,000$3,376,5750.12%
AVIVA PLC 31,010,000$26,723,0230.11%

This page lists HAEMONETICS CORP MASS's shareholders in Q3 2023. To view HAEMONETICS CORP MASS's shareholder history, click here.